Marshall Wace North America’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$989K Buy
17,664
+11,065
+168% +$611K ﹤0.01% 922
2021
Q2
$390K Buy
+6,599
New +$371K ﹤0.01% 1229
2020
Q3
Sell
-210,566
Closed -$5.43M 1416
2020
Q2
$5.43M Buy
+210,566
New +$4.83M 0.04% 361

Other funds holding PGNY

Marshall Wace North America's PGNY Position: Q3 2021 in Review

Marshall Wace North America increased its Progyny (PGNY) stake by 168% in Q3 2021, buying an estimated $611K and bringing the position to 17,664 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Marshall Wace North America first reported a position in PGNY in Q2 2020 and has held it in 3 quarters since. The position peaked at $5.43M in Q2 2020. 263 funds tracked by Wall St. Rank hold PGNY as of Q3 2021.

  • Marshall Wace North America held 17,664 shares of Progyny worth $989K as of Q3 2021.
  • Marshall Wace North America bought 11,065 Progyny shares in Q3 2021, an estimated $611K.
  • Progyny made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #922 holding.
  • Marshall Wace North America first reported a position in Progyny in Q2 2020 and has held it in 3 quarters since.
  • Marshall Wace North America's Progyny position peaked at $5.43M in Q2 2020.
  • 263 funds tracked by Wall St. Rank held Progyny as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.